GWAS

GENETIC4 trials

Sponsors

University of Nevada, Las Vegas, Hospices Civils de Lyon, Cyprus Institute of Neurology and Genetics, Dr.dr.Irma Bernadette, SpKK (K)

Conditions

Acne VulgarisAutoimmune EncephalitisHemoglobinopathiesObesitySickle Cell DiseaseThalassemia AlphaThalassemia, Beta

Unknown Phase

GWAS in a Small Group of Metabolically Healthy Obese White Adults

CompletedNCT02105909

University of Nevada, Las VegasObesity

Start: 2009-05-31End: 2013-11-30Updated: 2014-04-07

GWAS in NMDAR Encephalitis

Hospices Civils de LyonAutoimmune Encephalitis

Start: 2020-12-15End: 2025-12-31Target: 2000Updated: 2022-02-07

Study of the Role of Genetic Modifiers in Hemoglobinopathies

RecruitingNCT05799118

Cyprus Institute of Neurology and GeneticsHemoglobinopathies, Sickle Cell Disease, Thalassemia Alpha +1

Start: 2022-10-01End: 2027-09-30Target: 30000Updated: 2024-03-20

Profiles Analysis of Genome Wide Association Study (GWAS) in Acne Vulgaris in Indonesia.

RecruitingNCT06501560

Dr.dr.Irma Bernadette, SpKK (K)Acne Vulgaris

Start: 2023-10-01End: 2024-08-17Target: 24Updated: 2024-07-15